Clinical Trials Directory

Trials / Conditions / Adrenoleukodystrophy

Adrenoleukodystrophy

25 registered clinical trials studyying Adrenoleukodystrophy4 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTreating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
NCT05003648
Massachusetts General HospitalPhase 4
CompletedBaby Detect : Genomic Newborn Screening
NCT05687474
Centre Hospitalier Universitaire de Liege
RecruitingModeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adu
NCT04925349
Assistance Publique - Hôpitaux de Paris
CompletedPlasma Exchange With Albumin in AMN Patients
NCT04303416
Pujol, Aurora, M.D.Phase 2 / Phase 3
RecruitingAdrenoleukodystrophy National Registry Study
NCT03789721
Masonic Cancer Center, University of Minnesota
WithdrawnEarly Diagnosis Of Childhood Cerebral ALD
NCT02948062
Masonic Cancer Center, University of Minnesota
CompletedConditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
NCT03513328
University of FloridaPhase 1 / Phase 2
CompletedA Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.
NCT03231878
Minoryx Therapeutics, S.L.Phase 2 / Phase 3
UnknownPrecision Exercise in Children With Malignant Hemopathies
NCT04090268
University of Milano BicoccaN/A
CompletedLeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
NCT02699190
Children's Hospital of Philadelphia
RecruitingThe Myelin Disorders Biorepository Project
NCT03047369
Children's Hospital of Philadelphia
CompletedNewborn Screening for Adrenoleukodystrophy
NCT02952482
National Taiwan University Hospital
UnknownAutologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy
NCT02559830
Shenzhen Second People's HospitalPhase 1 / Phase 2
CompletedMD1003-AMN MD1003 in Adrenomyeloneuropathy
NCT02961803
MedDay Pharmaceuticals SAPhase 2 / Phase 3
RecruitingUCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-
NCT02254863
Joanne Kurtzberg, MDPhase 1
CompletedHuman Placental-Derived Stem Cell Transplantation
NCT01586455
New York Medical CollegePhase 1
CompletedHSCT for High Risk Inherited Inborn Errors
NCT00383448
Masonic Cancer Center, University of MinnesotaPhase 2
UnknownClinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
NCT00278044
Far Eastern Memorial HospitalN/A
TerminatedA Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
NCT00545597
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 3
UnknownStudy of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoie
NCT00005900
Fairview University Medical Center
CompletedRandomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
NCT00004450
FDA Office of Orphan Products DevelopmentN/A
TerminatedEffect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
NCT00004418
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Phase 2
CompletedStem Cell Transplant for Inborn Errors of Metabolism
NCT00176904
Masonic Cancer Center, University of MinnesotaPhase 2 / Phase 3
CompletedCompassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
NCT00007020
Mirum Pharmaceuticals, Inc.Phase 3
TerminatedStudy of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442
University of CincinnatiN/A